Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945

[1]  H. Völzke,et al.  Microglia ablation alleviates myelin-associated catatonic signs in mice , 2017, The Journal of clinical investigation.

[2]  S. Hauser,et al.  Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial , 2017, The Lancet.

[3]  C. Schmitz,et al.  Combination of cuprizone and experimental autoimmune encephalomyelitis to study inflammatory brain lesion formation and progression , 2017, Glia.

[4]  M. Prinz,et al.  Microglia contribute to normal myelinogenesis and to oligodendrocyte progenitor maintenance during adulthood , 2017, Acta Neuropathologica.

[5]  H. Lassmann,et al.  Therapeutic inhibition of soluble brain TNF promotes remyelination by increasing myelin phagocytosis by microglia. , 2017, JCI insight.

[6]  Hai-tao Zhu,et al.  M2 microglia promotes neurogenesis and oligodendrogenesis from neural stem/progenitor cells via the PPARγ signaling pathway , 2017, Oncotarget.

[7]  Manoj Kumar,et al.  INGE GRUNDKE-IQBAL AWARD FOR ALZHEIMER’S RESEARCH: NEUROTOXIC REACTIVE ASTROCYTES ARE INDUCED BY ACTIVATED MICROGLIA , 2019, Alzheimer's & Dementia.

[8]  B. Castellano,et al.  Astrocyte‐targeted production of interleukin‐6 reduces astroglial and microglial activation in the cuprizone demyelination model: Implications for myelin clearance and oligodendrocyte maturation , 2016, Glia.

[9]  R. Ransohoff.  A polarizing question: do M1 and M2 microglia exist? , 2016, Nature Neuroscience.

[10]  W. Brück,et al.  Laquinimod prevents cuprizone-induced demyelination independent of Toll-like receptor signaling , 2016, Neurology: Neuroimmunology & Neuroinflammation.

[11]  V. Perry,et al.  CSF1R blockade slows the progression of amyotrophic lateral sclerosis by reducing microgliosis and invasion of macrophages into peripheral nerves , 2016, Scientific Reports.

[12]  A. Najafi,et al.  Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-β pathology. , 2016, Brain : a journal of neurology.

[13]  K. Tenbrock,et al.  Neurodegeneration Triggers Peripheral Immune Cell Recruitment into the Forebrain , 2016, The Journal of Neuroscience.

[14]  Mariana Vargas-Caballero,et al.  Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer’s-like pathology , 2016, Brain : a journal of neurology.

[15]  A. Maurelli,et al.  Evolution of Bacterial Pathogens Within the Human Host , 2016, Microbiology spectrum.

[16]  J. Kong,et al.  Quetiapine Inhibits Microglial Activation by Neutralizing Abnormal STIM1-Mediated Intercellular Calcium Homeostasis and Promotes Myelin Repair in a Cuprizone-Induced Mouse Model of Demyelination , 2015, Front. Cell. Neurosci..

[17]  B. West,et al.  Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice. , 2015, Brain : a journal of neurology.

[18]  Jennifer Luebke,et al.  Depletion of microglia and inhibition of exosome synthesis halt tau propagation , 2015, Nature Neuroscience.

[19]  Shuangyi Fan,et al.  Clemastine rescues behavioral changes and enhances remyelination in the cuprizone mouse model of demyelination , 2015, Neuroscience Bulletin.

[20]  R. Franco,et al.  Alternatively activated microglia and macrophages in the central nervous system , 2015, Progress in Neurobiology.

[21]  A. Najafi,et al.  Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice , 2015, Journal of Neuroinflammation.

[22]  K. Green,et al.  Elimination of Microglia Improves Functional Outcomes Following Extensive Neuronal Loss in the Hippocampus , 2015, The Journal of Neuroscience.

[23]  M. Colonna,et al.  TREM2 sustains microglial expansion during aging and response to demyelination. , 2015, The Journal of clinical investigation.

[24]  K. Green,et al.  Characterizing Newly Repopulated Microglia in the Adult Mouse: Impacts on Animal Behavior, Cell Morphology, and Neuroinflammation , 2015, PloS one.

[25]  Peter K. Stys,et al.  Inefficient clearance of myelin debris by microglia impairs remyelinating processes , 2015, The Journal of experimental medicine.

[26]  H. Neumann,et al.  CXCL10 Triggers Early Microglial Activation in the Cuprizone Model , 2015, The Journal of Immunology.

[27]  Ludovico Minati,et al.  In vivo quantitative magnetization transfer imaging correlates with histology during de‐ and remyelination in cuprizone‐treated mice , 2015, NMR in biomedicine.

[28]  O. Ciccarelli,et al.  Exploring the origins of grey matter damage in multiple sclerosis , 2015, Nature Reviews Neuroscience.

[29]  M. Wiesmann,et al.  Phenotypic and metabolic investigation of a CSF-1R kinase receptor inhibitor (BLZ945) and its pharmacologically active metabolite , 2015, Xenobiotica; the fate of foreign compounds in biological systems.

[30]  C. Branch,et al.  Phenotypic characterization of a Csf1r haploinsufficient mouse model of adult-onset leukodystrophy with axonal spheroids and pigmented glia (ALSP) , 2015, Neurobiology of Disease.

[31]  M. Xie,et al.  TREM2 regulates microglial cell activation in response to demyelination in vivo , 2015, Acta Neuropathologica.

[32]  Inki Kim,et al.  Disparate roles of zinc in chemical hypoxia-induced neuronal death , 2015, Front. Cell. Neurosci..

[33]  C. Beyer,et al.  Absence of CCL2 and CCL3 Ameliorates Central Nervous System Grey Matter But Not White Matter Demyelination in the Presence of an Intact Blood–Brain Barrier , 2015, Molecular Neurobiology.

[34]  Samuel Bernard,et al.  Dynamics of Oligodendrocyte Generation and Myelination in the Human Brain , 2014, Cell.

[35]  T. Wisniewski,et al.  The Role of TREM2 in Alzheimer’s Disease and Other Neurological Disorders , 2014, Journal of Alzheimer's disease & Parkinsonism.

[36]  Brian L. West,et al.  Colony-Stimulating Factor 1 Receptor Signaling Is Necessary for Microglia Viability, Unmasking a Microglia Progenitor Cell in the Adult Brain , 2014, Neuron.

[37]  M. Stangel,et al.  Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned , 2014, Front. Cell. Neurosci..

[38]  Sveinung Fjær,et al.  Deep Gray Matter Demyelination Detected by Magnetization Transfer Ratio in the Cuprizone Model , 2013, PloS one.

[39]  J. Thiessen,et al.  Quantitative MRI and ultrastructural examination of the cuprizone mouse model of demyelination , 2013, NMR in biomedicine.

[40]  Christina S. Leslie,et al.  CSF-1R inhibition alters macrophage polarization and blocks glioma progression , 2013, Nature Medicine.

[41]  Tracy J. Yuen,et al.  M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination , 2013, Nature Neuroscience.

[42]  C. Beyer,et al.  Cuprizone-Induced Demyelination as a Tool to Study Remyelination and Axonal Protection , 2013, Journal of Molecular Neuroscience.

[43]  J. Relton,et al.  Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival , 2013, The Journal of experimental medicine.

[44]  M. Daly,et al.  Variant TREM2 as risk factor for Alzheimer's disease. , 2013, The New England journal of medicine.

[45]  W. Baumgärtner,et al.  Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination. , 2013, Brain : a journal of neurology.

[46]  C. Wegner,et al.  Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination , 2012, Acta Neuropathologica.

[47]  M. Day,et al.  Magnetic resonance imaging and histological evidence for the blockade of cuprizone-induced demyelination in C57BL/6 mice , 2012, Neuroscience.

[48]  Markus Rudin,et al.  MRI signature in a novel mouse model of genetically induced adult oligodendrocyte cell death , 2012, NeuroImage.

[49]  C. Trebst,et al.  Lipopolysaccharide delays demyelination and promotes oligodendrocyte precursor proliferation in the central nervous system , 2011, Brain, Behavior, and Immunity.

[50]  J. Pollard,et al.  Absence of Colony Stimulation Factor-1 Receptor Results in Loss of Microglia, Disrupted Brain Development and Olfactory Deficits , 2011, PloS one.

[51]  Sjef Copray,et al.  The cuprizone animal model: new insights into an old story , 2009, Acta Neuropathologica.

[52]  Elisa Cerutti,et al.  Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and β-catenin , 2009, Nature Immunology.

[53]  Oded Gonen,et al.  Monitoring demyelination and remyelination by magnetization transfer imaging in the mouse brain at 9.4 T , 2008, Magnetic Resonance Materials in Physics, Biology and Medicine.

[54]  K. Myhr,et al.  The cuprizone model for demyelination , 2008, Acta neurologica Scandinavica. Supplementum.

[55]  Jens Frahm,et al.  Multicontrast MRI of remyelination in the central nervous system , 2005, NMR in biomedicine.

[56]  J Hennig,et al.  RARE imaging: A fast imaging method for clinical MR , 1986, Magnetic resonance in medicine.

[57]  D Matthaei,et al.  Dynamic digital subtraction imaging using fast low-angle shot MR movie sequence. , 1986, Radiology.

[58]  W. L. Benedict,et al.  Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.